This is a preview of subscription content, log in to check access.
Gao Y, et al. Clinical benefit from afatinib in an advanced squamous cell lung carcinoma patient harboring HER2 S310Y mutation: A case report. OncoTargets and Therapy 2018: 8705-8710, No. 11, 5 Dec 2018. Available from: URL: http://doi.org/10.2147/OTT.S182812 - ChinaCrossRefGoogle Scholar